
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

An immunotherapy combination increased progression-free survival among patients with advanced renal cell carcinoma.

A combination of ramucirumab plus cisplatin and capecitabine did not improve survival in gastric cancer.

Increasing myelin production by targeting oligodendrocytes shows promise as a treatment for multiple sclerosis.

Voluntary male circumcision and starting antiretroviral therapy reduced new cases of HIV by 42% in vulnerable regions.

Top news of the day from across the health care landscape.

THC found to slow the process of neurodegeneration, which affects nearly half of all patients with HIV.

Prescription drug list prices outpaced the rate of inflation every year from 2006 to 2015.

Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, highlights emerging trends in the specialty pharmacy landscape.

Tisagenlecleucel (Kymriah) produced an overall response rate of 53% in patients with lymphoma.

Liver cancer is the most common cancer caused by diabetes and obesity.

Top news of the day from across the health care landscape.

Treating aging patients with immunomodulatory drugs further increases the risk of infections.

A proposed Sandoz biosimilar of pegfilgrastim (Neulasta) demonstrated biosimilarity to the reference biologic.

A high number of patients with eosinophilic granulomatosis treated with mepolizumab achieve remission within 24 weeks compared with placebo patients.

Patients taking hydrochlorothiazide may be 7 times more likely to develop squamous cell carcinoma.

The presence of a nerve protein in the blood may indicate the development of new T1 and T2 lesions resulting from multiple sclerosis.

These findings could lead to novel a HIV vaccine.

Top news of the day from across the health care landscape.

Galcanezumab found to significantly decrease the average number of monthly migraine headache days.

This extended-release injectable suspension aims to prevent relapse in opioid-dependent patients after detox and treat alcoholism.

Diplomat Pharmacy Inc.’s Acquisition of National Pharmaceutical Services will improve patient management services.

Online consultations may reduce the need for in-person appointments, but challenges can still arise.

Ron Lanton III, Esq, president, True North Political Solutions, LLC, discusses how proposed legislations would affect pharmacy benefit manager relations with specialty pharmacies.

Ibrutinib (Imbruvica) plus rituximab increased progression-free survival among patients with Waldenström's macroglobulinemia.

Nearly 30,000 individuals were diagnosed with HIV in the European Region in 2016.

Top news of the day from across the health care landscape.

A small number of multiple sclerosis cases following vaccinations affected compliance with vaccination recommendations.

Patients with cancer and caregivers said that the internet helped them to make informed care-related decisions.